Compare Humana Inc (HUM) vs MasterCard Inc (MA) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Humana Inc vs MasterCard Inc — how do they compare? Humana Inc trades at $377.63 (market cap $46.31B), while MasterCard Inc trades at $565.4 (market cap $493.34B). The key difference: MasterCard Inc is far larger — about 10.7× Humana Inc's market cap, and Humana Inc pays the higher dividend (0.92%). Which is the better fit depends on your goals.
| HUM | MA | |
|---|---|---|
Market Cap | $46.31B | $493.34B |
Sector | Health | Consumer Cyclical |
52-Week High | $409.42 | $598.96 |
52-Week Low | $163.67 | $471.55 |
Enterprise Value | $53.67B | $506.38B |
Dividend Yield | 0.92% | 0.62% |
Volume | — | 4,635,698 |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Humana (HUM) trades at $385.00, up 4.82% today, with a bullish technical outlook and analyst consensus price target of $399.53. Recent earnings beats in Q1 and Q2 2026, alongside revenue growth to $129.66 billion in 2025, support fundamentals, though net margins have compressed. The company is expanding its Medicaid business and targeting margin improvements by 2027.
The stock offers upside to consensus targets but faces risks from Medicare Advantage margin pressures and regulatory changes. Profitability trends are weak despite revenue growth, requiring successful cost management to meet 2028 targets. Institutional sentiment is mixed with a majority hold rating.
Mastercard (MA) trades at $565.60, up 0.47% today, with a bullish technical signal and strong institutional interest. Recent earnings beats, robust revenue growth to $32.79B in 2025, and high profitability margins (net income margin 46.34%) underscore fundamental strength. The stock faces competition from emerging payment technologies but maintains analyst optimism with a consensus price target of $660.85.
Outlook remains positive due to consistent earnings outperformance and strategic AI initiatives, though risks include payment disruption from stablecoins and high valuation multiples. Institutional holdings increased, with 79% of analysts rating it Buy, supporting upside potential amid market volatility.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Humana Inc
Humana is one of the largest private health insurers in the U.S. with a focus on administering Medicare Advantage plans. The firm has built a niche specializing in government-sponsored programs, with nearly all its medical membership stemming from individual and group Medicare Advantage, Medicaid, and the military's Tricare program. The firm is also a leader in stand-alone prescription drug plans for seniors enrolled in traditional fee-for-service Medicare. Humana offers employer-based plans primarily for small businesses along with specialty insurance offerings such as dental, vision, and life. Beyond medical insurance, the company provides other healthcare services, including primary-care services, at-home services, and pharmacy benefit management.
Read more on HUM →About MasterCard Inc
Mastercard Incorporated provides financial transaction processing services. The Company offers payment processing services for credit and debit cards, electronic cash, automated teller machines, and travelers checks. Mastercard serves customers worldwide.
Read more on MA →
